Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Solid Tumors × ribociclib × Clear all

Sponsor

Conditions

Breast Neoplasms 15 Glioma 3 Ovarian Neoplasms 2 Neoplasms 2 Neoplasm Metastasis 2 Multiple Endocrine Neoplasia Type 1 2 Melanoma 2 Diffuse Intrinsic Pontine Glioma 2 Thymus Neoplasms 1 Teratoma 1 Solid Tumors Harboring a BRAF V600 Mutation 1 Rhabdoid Tumor 1 Prostatic Neoplasms 1 Osteitis Deformans 1 Non functioning pancreatic endocrine tumor 1 Neuroendocrine Tumors 1 Neuroblastoma 1 Neoplasms, Germ Cell and Embryonal 1 Neoplasms by Site 1 Mesothelioma 1 Medulloblastoma 1 Lymphoma 1 Leukemia 1 Hematologic Neoplasms 1 Glioblastoma 1 Familial ependymoma 1 Fallopian Tube Neoplasms 1 Estrogen Receptor and/or Progesterone Receptor Positive 1 Cystadenocarcinoma, Serous 1 Breast Neoplasms, Male 1

Interventions

Gemcitabine 5 Paclitaxel 3 Nivolumab 3 cobimetinib 2 atezolizumab 2 Ramucirumab 2 Carboplatin 2 zansecimab 1 tocilizumab 1 tivozanib 1 tislelizumab 1 temsirolimus 1 ridaforolimus 1 plocabulin 1 pevonedistat 1 pembrolizumab 1 pamiparib 1 obinutuzumab 1 necitumumab 1 liposomal doxorubicin 1 lenvatinib 1 glasdegib 1 futuximab 1 demplatin pegraglumer 1 birinapant 1 adavosertib 1 Temozolomide 1 TAK-981 1 Sunitinib 1 Specimen Handling 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡